Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY26.75 CNY
Change Today -2.97 / -9.99%
Volume 3.6M
002349 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

nantong jinghua pharmaceu-a (002349) Snapshot

Open
CNY27.72
Previous Close
CNY29.72
Day High
CNY27.98
Day Low
CNY26.75
52 Week High
06/5/15 - CNY91.80
52 Week Low
07/17/14 - CNY17.70
Market Cap
7.0B
Average Volume 10 Days
5.6M
EPS TTM
CNY0.20
Shares Outstanding
260.0M
EX-Date
04/10/15
P/E TM
133.4x
Dividend
CNY0.10
Dividend Yield
0.37%
Current Stock Chart for NANTONG JINGHUA PHARMACEU-A (002349)

Related News

No related news articles were found.

nantong jinghua pharmaceu-a (002349) Related Businessweek News

No Related Businessweek News Found

nantong jinghua pharmaceu-a (002349) Details

Nantong Jinghua Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products primarily in China. The company offers its products in the forms of injections, tablets, capsules, granules, pills, powders, and syrups. It provides APIs, intermediates, western medicines, and Chinese traditional medicines, as well as special recommended processing products. The company was founded in 1957 and is based in Nantong, China.

Founded in 1957

nantong jinghua pharmaceu-a (002349) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nantong jinghua pharmaceu-a (002349) Key Developments

Nantong Jinghua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jun 23, 2015

Nantong Jinghua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jun 23, 2015., at 14:00 China Standard Time. Agenda: To consider eligibility for connected transaction regarding assets purchase through share offering and cash payment and raising matching fund; to consider scheme for connected transaction regarding assets purchase through share offering and cash payment and raising matching fund; to consider the restructuring constitutes connected transaction; to consider compliance and completeness of implementing the legal proceedings of the restructuring and the effectiveness of the legal document submitted; to consider the transaction is in compliance with the 2nd clause of 43rd article in the management measures on major assets restructuring of listed companies; to consider audit report, profit forecast audit report and evaluation report related to the restructuring; and to consider independence of evaluation institution, rationality of evaluation hypothesis, correlation between evaluation method and objective and fairness of evaluation pricing.

Nantong Jinghua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 15, 2015

Nantong Jinghua Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 15, 2015., at 14:30 China Standard Time. Agenda: To consider election of independent directors.

Nantong Jinghua Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Apr 17, 2015

Nantong Jinghua Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Apr 17, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002349:CH CNY26.75 CNY -2.97

002349 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002349.
View Industry Companies
 

Industry Analysis

002349

Industry Average

Valuation 002349 Industry Range
Price/Earnings 100.0x
Price/Sales 13.8x
Price/Book 5.5x
Price/Cash Flow 181.2x
TEV/Sales 12.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANTONG JINGHUA PHARMACEU-A, please visit www.ntjhzy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.